Highlights SCHOTT Pharma AG & Co. KGaA

Equities

Real-time Estimate Tradegate Other stock markets 03:16:15 2024-06-03 am EDT			5-day change	1st Jan Change
28.96 ^EUR	-1.16%		-3.87%	-12.80%

May. 28	SCHOTT PHARMA : Berenberg reiterates its Neutral rating	ZD
May. 21	Deutsche Bank Research lowers target for Schott Pharma - 'Buy'	DP

Deutsche Bank Research lowers target for Schott Pharma - 'Buy'	May. 21	DP
UBS lowers target for Schott Pharma to 33 euros - 'Neutral'	May. 20	DP
Barclays lowers Schott Pharma target to 25 euros - 'Equal Weight'	May. 15	DP
Schott Pharma falls sharply - 'High dependence on end markets'	May. 15	DP
Schott Pharma warns of weak syringe sales - share price slide	May. 15	DP
Schott Pharma falls sharply	May. 15	DP
Schott Pharma warns of weak syringe sales in the coming year	May. 14	DP
Gerresheimer very weak - Certain uncertainties about outlook	Apr. 11	DP
Weight-loss drug deals to drive around 4% of Gerresheimer yearly growth, CEO says	Mar. 29	RE
Dpa-AFX Overview: COMPANIES from 19.03.2024 - 15:15	Mar. 19	DP
Schott Pharma Plans New Syringe Manufacturing Facility in US	Mar. 19	MT
SCHOTT PHARMA : Jefferies reiterates its Neutral rating	Mar. 18	ZD
SCHOTT Pharma Announces to Expand in U.S. with New Prefillable Syringe Manufacturing Facility in Wilson, North Carolina	Mar. 18	CI
Dpa-AFX Overview: COMPANIES from 29.02.2024 - 15:15	Feb. 29	DP
Barclays rates Schott Pharma at 'Equal Weight' - Target 30 euros	Feb. 29	DP
Schott Pharma earns more at the start of the year thanks to lucrative products	Feb. 29	DP
SCHOTT Pharma AG & Co. KGaA Reports Earnings Results for the First Quarter Ended December 31, 2023	Feb. 27	CI
Deutsche Bank raises target for Schott Pharma to 42 euros - 'Buy'	Feb. 15	DP
Schott Pharma continues to chase records	Feb. 01	DP
Mainz-based specialty glass manufacturer Schott presents balance sheet	Jan. 30	DP

No results for this search